1. Home
  2. AOUT vs MOLN Comparison

AOUT vs MOLN Comparison

Compare AOUT & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Outdoor Brands Inc.

AOUT

American Outdoor Brands Inc.

HOLD

Current Price

$8.00

Market Cap

99.7M

Sector

Industrials

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.22

Market Cap

158.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOUT
MOLN
Founded
2020
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Ordnance And Accessories
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
99.7M
158.9M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
AOUT
MOLN
Price
$8.00
$4.22
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
$12.50
$8.38
AVG Volume (30 Days)
39.3K
2.1K
Earning Date
06-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
98.94
N/A
EPS
N/A
N/A
Revenue
$222,322,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.24
$285.71
P/E Ratio
N/A
N/A
Revenue Growth
10.55
N/A
52 Week Low
$6.26
$3.36
52 Week High
$13.74
$5.36

Technical Indicators

Market Signals
Indicator
AOUT
MOLN
Relative Strength Index (RSI) 33.04 32.57
Support Level $6.40 $4.02
Resistance Level $8.91 $4.61
Average True Range (ATR) 0.46 0.22
MACD -0.11 -0.09
Stochastic Oscillator 10.16 0.00

Price Performance

Historical Comparison
AOUT
MOLN

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: